These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34962532)

  • 1. Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA; 2021 Dec; 326(24):2521-2522. PubMed ID: 34962532
    [No Abstract]   [Full Text] [Related]  

  • 2. Two new pneumococcal vaccines - Prevnar 20 and Vaxneuvance.
    Med Lett Drugs Ther; 2021 Nov; 63(1638):188-190. PubMed ID: 35085216
    [No Abstract]   [Full Text] [Related]  

  • 3. Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey.
    Büyükcam A; Güdücüoğlu H; Karaman K; Gürbüz V; Aliyev E; Kara A; Ceyhan M
    Hum Vaccin Immunother; 2017 Aug; 13(8):1892-1894. PubMed ID: 28574743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?
    Desmet S; Verhaegen J; Van Ranst M; Peetermans W; Lagrou K
    Lancet Infect Dis; 2018 Aug; 18(8):830-831. PubMed ID: 30001857
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of pneumococcal disease in the United Kingdom--the start of a new era.
    Clarke SC
    J Med Microbiol; 2006 Aug; 55(Pt 8):975-980. PubMed ID: 16849715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia.
    Rockett RJ; Oftadeh S; Bachmann NL; Timms VJ; Kong F; Gilbert GL; Sintchenko V
    Sci Rep; 2018 Nov; 8(1):16969. PubMed ID: 30446692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?
    Esposito S; Principi N
    Future Microbiol; 2019 Jul; 14():921-923. PubMed ID: 31373218
    [No Abstract]   [Full Text] [Related]  

  • 8. Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable
    de Los Santos AM; Rodríguez-Weber MA; Sánchez-Márquez P; Traskine M; Carreño-Manjarrez R; Cervantes-Apolinar MY; Strezova A; Ruiz-Guiñazú J; Ortega-Barria E; Borys D
    Expert Rev Vaccines; 2020 Nov; 19(11):995-1010. PubMed ID: 33297773
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
    Shields B
    J Pediatr Health Care; 2001; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
    [No Abstract]   [Full Text] [Related]  

  • 10. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.
    Hausdorff WP; Hanage WP
    Hum Vaccin Immunother; 2016; 12(2):358-74. PubMed ID: 26905681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conjugate vaccine for the prevention of pediatric pneumococcal disease.
    Murray D; Jackson C
    Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conjugated pneumococcal vaccines].
    Reinert P
    Arch Pediatr; 1999; 6 Suppl 3():643s-646s. PubMed ID: 10429806
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
    Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
    Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
    Ojal J; Hammitt LL; Gaitho J; Scott JAG; Goldblatt D
    Vaccine; 2017 Aug; 35(35 Pt B):4652-4657. PubMed ID: 28739116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae among children attending group daycare in southeastern France.
    Dunais B; Bruno P; Touboul P; Degand N; Sakarovitch C; Fontas E; Haas H; Girard-Pipau F; Ruimy R; Pradier C
    Pediatr Infect Dis J; 2015 Mar; 34(3):286-8. PubMed ID: 25742079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive Pneumococcal Disease Surveillance, 1 October to 31 December 2016.
    Pennington K;
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E114-E119. PubMed ID: 28385146
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.
    Darkes MJ; Plosker GL
    Paediatr Drugs; 2002; 4(9):609-30. PubMed ID: 12175274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.